Company registration number 01482244 (England and Wales)
GREENFINGERS NURSERIES LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
GREENFINGERS NURSERIES LTD
CONTENTS
Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 7
GREENFINGERS NURSERIES LTD
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
-
0
-
0
Tangible assets
4
21,776
100,150
Current assets
Stocks
189,868
283,643
Debtors
5
10,080
6,804
Cash at bank and in hand
103,948
11,095
303,896
301,542
Creditors: amounts falling due within one year
6
(158,838)
(269,768)
Net current assets
145,058
31,774
Net assets
166,834
131,924
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
166,734
131,824
Total equity
166,834
131,924

For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 17 March 2026 and are signed on its behalf by:
Mr D O'Donnell
Director
Company registration number 01482244 (England and Wales)
GREENFINGERS NURSERIES LTD
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 January 2024
100
616,545
616,645
Year ended 31 December 2024:
Profit and total comprehensive income
-
15,279
15,279
Dividends
-
(500,000)
(500,000)
Balance at 31 December 2024
100
131,824
131,924
Year ended 31 December 2025:
Profit and total comprehensive income
-
34,910
34,910
Balance at 31 December 2025
100
166,734
166,834
GREENFINGERS NURSERIES LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -
1
Accounting policies
Company information

Greenfingers Nurseries Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Lumaneri House, Blythe Valley Park, Blythe Gate, Solihull, West Midlands, B90 8AH.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Revenue

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold land and buildings
0% and 5% Straight Line
Plant and equipment
20% Straight Line
Fixtures and fittings
33% Straight Line
Computers
25% Residual Balance
Motor vehicles
25% Straight Line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

GREENFINGERS NURSERIES LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 4 -
1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.5
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

GREENFINGERS NURSERIES LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 5 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.10
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

GREENFINGERS NURSERIES LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 6 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
7
7
4
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 January 2025
191,571
147,796
339,367
Additions
-
0
3,426
3,426
Disposals
(73,357)
(750)
(74,107)
At 31 December 2025
118,214
150,472
268,686
Depreciation and impairment
At 1 January 2025
117,572
121,645
239,217
Depreciation charged in the year
208
8,235
8,443
Eliminated in respect of disposals
-
0
(750)
(750)
At 31 December 2025
117,780
129,130
246,910
Carrying amount
At 31 December 2025
434
21,342
21,776
At 31 December 2024
73,999
26,151
100,150
GREENFINGERS NURSERIES LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 7 -
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
-
0
161
Other debtors
10,080
6,643
10,080
6,804
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
4,424
122,389
Taxation and social security
31,901
14,003
Other creditors
122,513
133,376
158,838
269,768
2025-12-31 2025-01-01 false false false 17 March 2026 CCH Software CCH Accounts Production 2025.300 No description of principal activity Mr D O'Donnell Mrs T O'Donnell Jerrom Secretarial Services Limited 01482244 2025-01-01 2025-12-31 01482244 2025-12-31 01482244 2024-12-31 01482244 core:LandBuildings 2025-12-31 01482244 core:OtherPropertyPlantEquipment 2025-12-31 01482244 core:LandBuildings 2024-12-31 01482244 core:OtherPropertyPlantEquipment 2024-12-31 01482244 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 01482244 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 01482244 core:CurrentFinancialInstruments 2025-12-31 01482244 core:CurrentFinancialInstruments 2024-12-31 01482244 core:ShareCapital 2025-12-31 01482244 core:ShareCapital 2024-12-31 01482244 core:RetainedEarningsAccumulatedLosses 2025-12-31 01482244 core:RetainedEarningsAccumulatedLosses 2024-12-31 01482244 core:ShareCapital 2023-12-31 01482244 core:RetainedEarningsAccumulatedLosses 2023-12-31 01482244 bus:Director1 2025-01-01 2025-12-31 01482244 core:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 01482244 2024-01-01 2024-12-31 01482244 core:RetainedEarningsAccumulatedLosses 2025-01-01 2025-12-31 01482244 core:LandBuildings core:OwnedOrFreeholdAssets 2025-01-01 2025-12-31 01482244 core:PlantMachinery 2025-01-01 2025-12-31 01482244 core:FurnitureFittings 2025-01-01 2025-12-31 01482244 core:ComputerEquipment 2025-01-01 2025-12-31 01482244 core:MotorVehicles 2025-01-01 2025-12-31 01482244 core:LandBuildings 2024-12-31 01482244 core:OtherPropertyPlantEquipment 2024-12-31 01482244 2024-12-31 01482244 core:LandBuildings 2025-01-01 2025-12-31 01482244 core:OtherPropertyPlantEquipment 2025-01-01 2025-12-31 01482244 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 01482244 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 01482244 bus:FRS102 2025-01-01 2025-12-31 01482244 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 01482244 bus:Director2 2025-01-01 2025-12-31 01482244 bus:CompanySecretary1 2025-01-01 2025-12-31 01482244 bus:FullAccounts 2025-01-01 2025-12-31 xbrli:pure xbrli:shares iso4217:GBP